IRIS
LUZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.139
AS - Asia 3.881
EU - Europa 1.995
SA - Sud America 875
AF - Africa 84
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.951
SG - Singapore 1.691
CN - Cina 924
IT - Italia 772
BR - Brasile 674
VN - Vietnam 449
IN - India 385
DE - Germania 358
GB - Regno Unito 270
SE - Svezia 154
FI - Finlandia 151
CA - Canada 120
AR - Argentina 84
NL - Olanda 80
HK - Hong Kong 73
IR - Iran 56
BD - Bangladesh 47
MX - Messico 45
RU - Federazione Russa 37
ID - Indonesia 36
TR - Turchia 35
EC - Ecuador 34
JP - Giappone 31
IQ - Iraq 25
PL - Polonia 25
ES - Italia 23
ZA - Sudafrica 22
FR - Francia 21
PK - Pakistan 21
UA - Ucraina 21
CL - Cile 20
AU - Australia 19
CO - Colombia 18
IL - Israele 16
CZ - Repubblica Ceca 15
TW - Taiwan 14
MA - Marocco 13
PY - Paraguay 13
PH - Filippine 11
UZ - Uzbekistan 11
PE - Perù 10
UY - Uruguay 10
VE - Venezuela 10
AT - Austria 9
EG - Egitto 9
RO - Romania 9
IE - Irlanda 7
KE - Kenya 7
RS - Serbia 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
EU - Europa 6
DZ - Algeria 5
ET - Etiopia 5
HU - Ungheria 5
OM - Oman 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BH - Bahrain 4
CH - Svizzera 4
JO - Giordania 4
NG - Nigeria 4
NP - Nepal 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AL - Albania 3
AO - Angola 3
BE - Belgio 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GR - Grecia 3
JM - Giamaica 3
LT - Lituania 3
MG - Madagascar 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CG - Congo 2
CU - Cuba 2
DK - Danimarca 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
KG - Kirghizistan 1
KR - Corea 1
Totale 11.991
Salva come PNG Salva come JPEG
Città #
San Jose 886
Singapore 544
Chandler 533
Ashburn 468
Dallas 321
Santa Clara 309
Munich 292
Bengaluru 275
Hefei 274
Milan 243
Chicago 232
Princeton 211
Lawrence 210
London 204
Ho Chi Minh City 175
Wilmington 132
Beijing 108
Hanoi 85
Helsinki 85
Ottawa 82
Des Moines 68
São Paulo 67
Hong Kong 63
Los Angeles 50
Turku 48
Boardman 46
Shanghai 38
Rome 37
Catanzaro 36
New York 32
Naples 31
Guangzhou 29
Redwood City 27
Mumbai 23
Cittanova 22
Hanover 22
Pune 22
Haiphong 21
Da Nang 19
Norwalk 19
San Francisco 18
Rio de Janeiro 17
The Dalles 17
Council Bluffs 16
Montreal 16
Orem 16
Phoenix 16
Redmond 16
Warsaw 16
Brooklyn 15
Istanbul 15
Palermo 14
Shenzhen 14
Tokyo 14
Belo Horizonte 13
Brasília 13
Chennai 13
Dhaka 13
Stockholm 13
Bari 12
Guayaquil 12
Mendicino 12
Osaka 12
Amsterdam 11
Curitiba 11
Hải Dương 11
Jyväskylä 11
Atlanta 10
Campinas 10
Cosenza 10
Salvador 10
San Nicola Manfredi 10
Tashkent 10
Thái Nguyên 10
Biên Hòa 9
Boston 9
Montevideo 9
Olomouc 9
Praia A Mare 9
Charlotte 8
Jiaxing 8
Johannesburg 8
Mexico City 8
Quito 8
Santo André 8
Tehran 8
Catania 7
Collegeville 7
Dublin 7
Fortaleza 7
Karachi 7
Manchester 7
Marília 7
Santiago 7
Viamão 7
Vienna 7
Ankara 6
Assago 6
Bắc Ninh 6
Cape Town 6
Totale 7.031
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 247
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 199
Dietary polyphenolsand non-alcoholic fatty liver disease 105
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 90
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials 90
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 90
Applications of Text Mining techniques to extract meaningful information from gastroenterology medical reports 87
7-Ketolithocholic acid administration in man: effects on biliary lipid composition, serum bile acid pattern and evaluation of the cholelitholytic potential 81
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 80
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 79
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 76
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 75
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 73
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 73
The role of gluten-free diet in nonalcoholic fatty liver disease development 73
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 72
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 72
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopiche di mucosa gastrica antrale 71
Analisi isotipica delle immunoglobuline prodotte da linfociti isolati con un metodo originale da biopsie endoscopicher di mucosa gastrica antrale 70
Antral nodularity identifies children infected with Helicobacter pylori with higher grades of gastric inflammation 70
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 69
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 69
Altered IgG4 renal clearance in patients with inflammatory bowel diseases. Evidence for a subclinical impairment of protein charge renal selectivity 69
Bioactive interleukin-18 expression is up-regulated in Crohn’s disease 69
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 69
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 68
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 68
Antral nodularity identifies Helicobacter pylori infected children with higher grades of gastric inflammation 67
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 66
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 66
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 66
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 65
Ancient wheats: beneficial effects on insulin resistance 64
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 63
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 63
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 63
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 62
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 62
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 62
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 62
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 61
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 61
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 61
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 61
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 60
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 60
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 59
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 58
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 58
Primary clarithromycin resistance in Helicobacter pylori: The multicentric Italian clarithromycin resistance observational (MICRO) study 58
Gut microbiota and non-alcoholic fatty liver disease 58
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 56
Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacter Pylori infection 56
La calcolosi della colecisti 55
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 55
Bioactive IL-18 expression is up-regulated in Crohn's disease 55
Antibacterial drugs in Crohn's disease 55
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 55
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 54
Machine Learning Approaches in Inflammatory Bowel Disease 54
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 54
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 54
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 54
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum 53
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 53
Ruolo della colonscopia e delle biopsie multiple nella sorveglianza dei pazienti affetti da colite ulcerosa di lunga durata 53
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 53
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 52
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells 52
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 51
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 51
Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 51
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 51
Helicobacter pylori infection in children with celiac disease: prevalence and clinicopathological features 50
Tumeurs benignes et malignes du duodenum 50
Bone mineralization in celiac disease 50
Critical review on the use and abuse of alcohol. When the dose makes the difference. 50
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 49
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 49
NON ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH INCREASED CENTRAL BODY FAT BY DUAL-ENERGY X-RAY ABSORPTIOMETRY 49
Liver injury associated with high value of D-dimer plasmatic level in COVID-19 patients 48
Circulating D dimer in inflammatory bowel disease 48
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 48
Gut microbiota changes and chronic hepatitis C virus infection 48
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 48
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 47
Changes in the mucosal expression of interleukin 15 in Helicobacter pylori associated gastritis 47
Testing for serum IgG antibodies to Helicobacter pylori cytotoxin-associated protein detects children with higher grades of gastric inflammation 47
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 47
Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease 47
Author correction to Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells [Infect. Immun. 72, 9, (2004) 5019-5026] 47
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 46
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 46
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 46
Suggestion against an oral-oral route of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. 46
Interazione Ospite-Batterio 46
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 46
Seroepidemiology of Helicobacter pylori infection and hepatitis A in a rural area: evidence against a common mode of transmission 45
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 45
Evidence favouring the gastro-oral route in the transmission of Helicobacter pylori infection in children. European Journal of Gastroenterology and Hepatology 45
Totale 6.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 10 4 3
2021/2022568 13 11 16 108 54 8 20 135 54 40 89 20
2022/20231.896 426 60 72 159 186 146 31 151 291 194 147 33
2023/2024952 223 98 71 63 32 219 34 61 45 26 27 53
2024/20252.934 386 182 176 67 173 388 192 155 421 90 250 454
2025/20265.463 294 616 641 1.064 595 235 700 354 682 282 0 0
Totale 12.295